Work

LBP-025 Elafibranor impacts inflammatory, fibrotic and symptom-associated markers in patients with primary biliary cholangitis: Proteomic results from the ELATIVE® trial

Year: 2025

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(25)00444-1

Authors: Mark Swain, Pascale Plas, Maria del Pilar Schneider, Jacquie Maignel, Aurélie Martin, Nuno Antunes, George Harb, Hugo Gomes da Silva, Benjamin Miller, Andrew L. Mason

Language: English

Topic: Liver Diseases and Immunity

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410162417

Cites:

Cited by: 1

Related to: 10